Mice Deficient for Soluble Adenylyl Cyclase Are Infertile because of a Severe Sperm-Motility Defect
Esposito, Gloria, Jaiswal, Byjay S., Xie, Fang, Magda A. M. Krajnc-Franken, Tamara J. A. A. Robben, Strik, Ankie M., Kuil, Cor, Ria L. A. Philipsen, van Duin, Marcel, Conti, Marco, Gossen, Jan A., Beavo, Joseph A.
Published in Proceedings of the National Academy of Sciences - PNAS (02.03.2004)
Published in Proceedings of the National Academy of Sciences - PNAS (02.03.2004)
Get full text
Journal Article
Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4 + T-lymphocyte counts
Bota, Daniela A, Chung, Jinah, Dandekar, Manisha, Carrillo, Jose A, Kong, Xiao-Tang, Fu, Beverly D, Hsu, Frank Pk, Schönthal, Axel H, Hofman, Florence M, Chen, Thomas C, Zidovetzki, Raphael, Pretto, Chrystel, Strik, Ankie, Schijns, Virgil Ejc, Stathopoulos, Apostolos
Published in CNS oncology (01.07.2018)
Published in CNS oncology (01.07.2018)
Get full text
Journal Article
Early postnatal lethality and cardiovascular defects in CXCR7-deficient mice
Gerrits, Han, van Ingen Schenau, Dorette S., Bakker, Nicole E.C., van Disseldorp, Ad J.M., Strik, Ankie, Hermens, Laura S., Koenen, Tim B., Krajnc-Franken, Magda A.M., Gossen, Jan A.
Published in Genesis (New York, N.Y. : 2000) (01.05.2008)
Published in Genesis (New York, N.Y. : 2000) (01.05.2008)
Get full text
Journal Article
CTIM-09. DOUBLE-BLINDED, PLACEBO CONTROLLED PHASE 2 STUDY OF ERC1671 IN RECURRENT GLIOBLASTOMA: VACCINE OVERALL SURVIVAL IN BEVACIZUMAB NAIVE AND BEVACIZUMAB RESISTANT PATIENTS
Bota, Daniela, Taylor, Thomas, Kong, Xiao-Tang, Fu, Beverly, Hsu, Frank, Strik, Ankie, Schijns, Virgil, Stathopoulos, Apostolos
Published in Neuro-oncology (Charlottesville, Va.) (09.11.2020)
Published in Neuro-oncology (Charlottesville, Va.) (09.11.2020)
Get full text
Journal Article
ATIM-42. DOUBLE-BLINDED, PLACEBO CONTROLLED PHASE 2 STUDY OF ERC1671 IN RECURRENT GLIOBLASTOMA: OS CORRELATIONS WITH INITIAL AND MAXIMUM CD4+T LYMPHOCYTE COUNT IN THE PERIPHERAL BLOOD
Bota, Daniela, Taylor, Thomas, Xiao-Tang, Kong, Fu, Beverly, Alsharif, Mohamad, Pretto, Chrystel, Strik, Ankie, Schijns, Virgil, Stathopoulos, Apostolos
Published in Neuro-oncology (Charlottesville, Va.) (11.11.2019)
Published in Neuro-oncology (Charlottesville, Va.) (11.11.2019)
Get full text
Journal Article
HOUT-17. A PRELIMINARY DATA REPORT ON A PHASE 2 STUDY OF ERC1671 IN RECURRENT GLIOBLASTOMA
Bota, Daniela, Chung, Jinah, Carrillo, Jose, Kong, Xiao-Tang, Fu, Beverly, Pretto, Chrystel, Strik, Ankie, Schijns, Virgil, Stathopoulos, Apostolos
Published in Neuro-oncology (Charlottesville, Va.) (06.11.2017)
Published in Neuro-oncology (Charlottesville, Va.) (06.11.2017)
Get full text
Journal Article
ATIM-20. A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED PHASE 2 STUDY OF THE ERC-1671 (GLIOVAC) VACCINE IN COMBINATION WITH BEVACIZUMAB (BEV) IN RECURRENT GBM PATIENTS: SAFETY LEAD-IN ANALYSIS
Bota, Daniela, Carrillo, Jose, Kong, Xiao-Tang, Fu, Dan, Chung, Jinah, Pretto, Chrystel, Strik, Ankie, Schijns, Virgil, Stathopoulos, Apostolos
Published in Neuro-oncology (Charlottesville, Va.) (01.11.2016)
Published in Neuro-oncology (Charlottesville, Va.) (01.11.2016)
Get full text
Journal Article
ATIM-28. PHASE 2 STUDY OF ERC1671 PLUS BEVACIZUMAB VS BEVACIZUMAB PLUS PLACEBO IN RECURRENT GBM INTERIM RESULTS AND CORRELATIONS WITH CD4+ T LYMPHOCYTE COUNTS
Bota, Daniela A, Chung, Jinah, Dandekar, Manisha, Carrillo, Jose A, Kong, Xiao-tang, Beverly Fu, Dan, Hsu, Frank P K, Schönthal, Alex H, Hofman, Florence M, Chen, Thomas C, Zidovetzki, Raphael, Pretto, Chrystel, Strik, Ankie, Schijns, Virgil E J C, Stathopoulos, Apostolos
Published in Neuro-oncology (Charlottesville, Va.) (05.11.2018)
Published in Neuro-oncology (Charlottesville, Va.) (05.11.2018)
Get full text
Journal Article
Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4
Bota, Daniela A, Chung, Jinah, Dandekar, Manisha, Carrillo, Jose A, Kong, Xiao-Tang, Fu, Beverly D, Hsu, Frank PK, Schönthal, Axel H, Hofman, Florence M, Chen, Thomas C, Zidovetzki, Raphael, Pretto, Chrystel, Strik, Ankie, Schijns, Virgil EJC, Stathopoulos, Apostolos
Published in CNS oncology (01.08.2018)
Published in CNS oncology (01.08.2018)
Get full text
Journal Article